Because systemic antagonism of TNFα in humans is currently possible with a variety of strategies such as use of antibodies or recombinant receptors that bind and antagonize TNFα it would be appropriate to prospectively study the potential therapeutic role of such antagonism in modulating silica-induced lung injury and improving the outcome of lung transplantation for silicosis. This evidence concerns the gene TNF and silicosis.